Work

Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: PubMed

Authors: Paul Chervinsky, Anjuli Nayak, Anthony Rooklin, Melvyn Danzig

Institution: Northeast Medical Research Associates

Language: English

Topic: Allergic Rhinitis and Sensitization

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W36950519

FWCI: 0.752

Cites:

Cited by: 27

Related to: 10